Searchable abstracts of presentations at key conferences in endocrinology

ea0050p189 | Clinical Biochemistry | SFEBES2017

Diagnosis and management of hyponatraemia in patients with cancer

Grigoriadou Victoria Chatzimavridou , Notarstefano Chiara , Monaghan Philip , Trainer Peter , Higham Claire

Background: Hyponatraemia (most commonly secondary to SIADH) is very common in cancer patients; it is associated with delays to oncology treatment and mortality.Aim: To evaluate the number of patients with hyponatraemia at a tertiary referral cancer centre and assess adherence to national recommendations for investigations and treatment.Methods: All biochemistry results (in-patient and outpatient) analys...

ea0050p189 | Clinical Biochemistry | SFEBES2017

Diagnosis and management of hyponatraemia in patients with cancer

Grigoriadou Victoria Chatzimavridou , Notarstefano Chiara , Monaghan Philip , Trainer Peter , Higham Claire

Background: Hyponatraemia (most commonly secondary to SIADH) is very common in cancer patients; it is associated with delays to oncology treatment and mortality.Aim: To evaluate the number of patients with hyponatraemia at a tertiary referral cancer centre and assess adherence to national recommendations for investigations and treatment.Methods: All biochemistry results (in-patient and outpatient) analys...

ea0034p45 | Clinical biochemistry | SFEBES2014

Serum 5HIAA: a better biomarker than urine for detecting and monitoring neuroendocrine tumours?

Adaway Joanne , Dobson Rebecca , Walsh Jennifer , Cuthbertson Daniel , Monaghan Philip , Valle Juan , Devlin Neil , Keevil Brian

Background: 5-hydroxyindole acetic acid (5-HIAA) (a metabolite of serotonin) is used as a marker for patients with serotonin-secreting neuroendocrine tumours. Currently, most laboratories measure 24 h 5-HIAA excretion in urine samples. Urine collections are cumbersome for the patient and impact on their daily activities; they are consequently often poorly performed, leading to over- or under-collection of urine and inaccurate 5-HIAA excretion results. Furthermore, large volume...

ea0034p50 | Clinical biochemistry | SFEBES2014

Reference ranges for salivary steroid measurement during short synacthen tests

Shotton Rohan , Perogamvros Ilias , Keevil Brian , Monaghan Philip , Trainer Peter , Higham Claire

Background: The use of salivary cortisol is well validated in the diagnosis of Cushing’s syndrome but routine use of salivary measurements during dynamic tests of HPA axis sufficiency is uncommon and reference ranges are not established. Salivary cortisol (SalF) and cortisone (SalE) measurements by LC–MS have several advantages including ease of collection and more accurate reflection of unbound serum cortisol levels in conditions of altered CBG levels (e.g. oestroge...

ea0070aep657 | Pituitary and Neuroendocrinology | ECE2020

The impact of variations in laboratory measurements of IGF-1 and random growth hormone on the classification of acromegaly disease activity status: Lessons from the UK Acromegaly Register Reference Laboratory

Bashir Bilal , Adam Safwaan , Monaghan Philip , Plummer Zoe , Archer Natasha , Ayuk John , Trainer Peter

Background: The UK Acromegaly Register contains data for 2700 patients. IGF-1 and random growth hormone (GH) measurements are used for disease monitoring. The registry reference laboratory (RRL) uses the Immunodiagnostic systems (IDS)-iSYS immunoassay platform for GH and IGF-1. The RRL uses age- and sex-specific reference ranges for IGF-1. We compared IGF-1 and GH results fromlocal laboratories to those of the RRL (pre-defined as the Gold standard) to determine the extent of d...

ea0094p171 | Adrenal and Cardiovascular | SFEBES2023

A clinical case demonstrating the challenges in diagnosing and managing Paraneoplastic Cushing’s Syndrome

Iqbal Zohaib , Ho Jan , Walker Leanne , White Ann , Monaghan Philip , Thirkettle Sally , Gulamhusein Aziz , Keevil Brian , Mansoor Wasat , Adam Safwaan

We present a case of a 62-year-old lady with a grade 3 well-differentiated metastatic gastric-neuroendocrine tumour complicated by symptoms of CS (weight-gain, bruising, proximal weakness) which developed over 4 weeks. She had progressive disease after exhausting all conventional anti-neoplastic therapeutic options. Screening tests revealed raised 24-h urinary free cortisol (3460 nmol/24h[<165]), post-overnight dexamethasone suppression serum cortisol (serF) 1200 nmol/l(&#...

ea0081ep698 | Pituitary and Neuroendocrinology | ECE2022

Age and puberty based IGF-1 normative data in healthy children from North India.

Malhotra Bhanu , Teja Kv Ravi , Bhadada Sanjay , Rastogi Ashu , Bhansali Anil , Sachdeva Naresh , Minz Ranjana Walker , Walia Rama , Prakash Mahesh , Aggarwal Arun Kumar , Dewan Gajinder , Das Liza , Monaghan Philip , Trainer Peter , Korbonits Marta , Marwaha Raman Kumar , Dutta Pinaki

Context: Serum IGF-1 levels are of paramount importance for diagnosis and management of growth related disorders. The reference range of IGF- 1 should be ethnicity and Tanner specific. Indian data on the same is scarce and there is a need to develop the same.Objective: To develop age, sex and Tanner based normative reference range of serum IGF-1 level for Indian children and correlate the same with peri-pubertal hormonal parameters.<p class="abstext"...